Movement Alert｜JOINN Rises 6.22% in Regular Trading, CXO Sector Recovery and 3.1 Billion Yuan Backlog Boost Sentiment

Market Focus08-17

On August 17, JOINN (06127) rose 6.22% in regular trading, trading at 26.72 HKD/share, with turnover of 50.31 million HKD.

On the news front, the company recently disclosed on its investor relations platform that its backlog stood at 3.1 billion RMB as of Q1 end. Legacy low-price orders have been clearing in an orderly manner since industry demand recovered in late Q4 of the prior year. Notably, non-human primate experimental animal prices and new order signing prices have both rebounded compared to earlier periods.

The broader CXO sector rallied in tandem, with institutional research reports citing clear upward signals in industry prosperity driven by a global biotech financing recovery. Within the Life Sciences Tools and Services sector, GENSCRIPT BIO rose 5.55%, WUXI BIO rose 4.92%, WUXI APPTEC rose 4.46%, XTALPI rose 3.37%, and INSILICO rose 3.01%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128705792?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 10:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128705792","market":"hk","top_or_hot":-1,"title":"Movement Alert｜JOINN Rises 6.22% in Regular Trading, CXO Sector Recovery and 3.1 Billion Yuan Backlog Boost Sentiment","media":"Market Focus","content":"<p><p>On August 17, JOINN (06127) rose 6.22% in regular trading, trading at 26.72 HKD/share, with turnover of 50.31 million HKD.</p><p>On the news front, the company recently disclosed on its investor relations platform that its backlog stood at 3.1 billion RMB as of Q1 end. Legacy low-price orders have been clearing in an orderly manner since industry demand recovered in late Q4 of the prior year. Notably, non-human primate experimental animal prices and new order signing prices have both rebounded compared to earlier periods.</p><p>The broader CXO sector rallied in tandem, with institutional research reports citing clear upward signals in industry prosperity driven by a global biotech financing recovery. Within the Life Sciences Tools and Services sector, GENSCRIPT BIO rose 5.55%, WUXI BIO rose 4.92%, WUXI APPTEC rose 4.46%, XTALPI rose 3.37%, and INSILICO rose 3.01%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JOINN Rises 6.22% in Regular Trading, CXO Sector Recovery and 3.1 Billion Yuan Backlog Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JOINN Rises 6.22% in Regular Trading, CXO Sector Recovery and 3.1 Billion Yuan Backlog Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-17 10:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 17, JOINN (06127) rose 6.22% in regular trading, trading at 26.72 HKD/share, with turnover of 50.31 million HKD.</p><p>On the news front, the company recently disclosed on its investor relations platform that its backlog stood at 3.1 billion RMB as of Q1 end. Legacy low-price orders have been clearing in an orderly manner since industry demand recovered in late Q4 of the prior year. Notably, non-human primate experimental animal prices and new order signing prices have both rebounded compared to earlier periods.</p><p>The broader CXO sector rallied in tandem, with institutional research reports citing clear upward signals in industry prosperity driven by a global biotech financing recovery. Within the Life Sciences Tools and Services sector, GENSCRIPT BIO rose 5.55%, WUXI BIO rose 4.92%, WUXI APPTEC rose 4.46%, XTALPI rose 3.37%, and INSILICO rose 3.01%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1128705792","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128705792","pubTimestamp":1786932395,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 17, JOINN (06127) rose 6.22% in regular trading, trading at 26.72 HKD/share, with turnover of 50.31 million HKD.On the news front, the company recently disclosed on its investor relations...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势提醒|JOINN常规交易上涨6.22%，CXO板块复苏，31亿元积压订单提振人气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On August 17, JOINN (06127) rose 6.22% in regular trading, trading at 26.72 HKD/share, with turnover of 50.31 million HKD.On the news front, the company recently disclosed on its investor relations platform that its backlog stood at 3.1 billion RMB as of Q1 end. Legacy low-price orders have been clearing in an orderly manner since industry demand recovered in late Q4 of the prior year. Notably, non-human primate experimental animal prices and new order signing prices have both rebounded compared to earlier periods.The broader CXO sector rallied in tandem, with institutional research reports citing clear upward signals in industry prosperity driven by a global biotech financing recovery. Within the Life Sciences Tools and Services sector, GENSCRIPT BIO rose 5.55%, WUXI BIO rose 4.92%, WUXI APPTEC rose 4.46%, XTALPI rose 3.37%, and INSILICO rose 3.01%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128705792","isCrawlerRequest":true}